Search Results
Jul 03, 2026, 03:41 ET CGTN: Co vzbuzuje důvěru lidí v čínskou vládnoucí stranu?
Čchung-čchingu, kde úspěšně zprostředkoval vyřešení více než 2500 místních sporů. Ve venkovské provincii Che-nan zatím vyvedl vesnický stranický tajemník Li Liancheng vesnici Si-sin-čuang z hluboké chudoby a pomohl ji proměnit ze strádající obce v celostátně uznávaný vzor oživení venkova. V čele průmyslových
More news about: CGTN
Jul 03, 2026, 03:01 ET THAD Presents the China Pavilion at the UIA World Congress of Architects, Showcasing China's Thoughts on Contemporary Architecture
Architecture at the Opening Ceremony UIA President Regina Gonthier hailed the exhibition as "unprecedented in scale and remarkable in quality." Li Cundong, Secretary-General of the Architectural Society of China, noted that the China Pavilion is the first carbon-neutral China Pavilion in the history
More news about: Architectural Design & Research Institute of Tsinghua University (THAD)
Jul 02, 2026, 11:35 ET CGTN -- что стимулирует доверие людей к правящей партии Китая?
десятилетий, успешно выступая посредником в более чем 2500 местных споров. Между тем, в сельской местности Хэнань глава деревенской партии Ли Ляньчэн (Li Liancheng) вытащил Сисиньчжуан из глубокой нищеты, помогая превратить его из борющейся деревни в национально признанную модель возрождения сельских районов.
More news about: CGTN
Jul 02, 2026, 10:53 ET Ribo und Madrigal erreichen ersten wichtigen Meilenstein bei der Weiterentwicklung neuartiger siRNA-Therapien für MASH
Kooperationsprogramm gemeinsam voranzutreiben und Patienten weltweit, die an MASH leiden, vielversprechende neue Behandlungsmöglichkeiten anzubieten", sagte Li-Ming Gan, Co-Geschäftsführer und Präsident für globale F&E von Ribo.Informationen zu Suzhou Ribo Life Science Co. Ltd. und Ribocure Pharmaceuticals
More news about: Suzhou Ribo Life Science Co., Ltd.
Jul 02, 2026, 10:30 ET Hospital Procurement Expectations Outpace AI Regulation for Medical Device Manufacturers
AI governance risk falling behind customer expectations."Medical device manufacturers already prepare for regulatory approval," said Dr. Yuan Li, Director of Medical Business at DQS. "Soon, they'll also need to prepare for procurement approval. Healthcare organizations want confidence that connected
More news about: DQS
Jul 02, 2026, 10:15 ET Data Center Certification Market worth $3.05 billion by 2032 - Exclusive Report by MarketsandMarkets™
Data Center Battery Market by UPS (<100 kWh, 100-500 kWh, 500 kWh-1 MWh, >1 MWh), BESS (<1 MWh, 1-30 MWh, >30 MWh), Battery Type (Li-ion, Lead-acid, Sodium-ion, Flow Battery), Data Center (Enterprise, Hyperscale, Colocation) - Global Forecast to 2032
More news about: MarketsandMarkets
Jul 02, 2026, 09:12 ET Global Times: Summer Davos reaffirms openness and cooperation amid global uncertainty
new opportunities we offer, and join us in building a brighter future," Li said.For enterprises worldwide, "China Opportunity 2.0" represents comprehensive innovation-driven empowerment and high-return investment prospect, Li said. "For global development, 'China Opportunity 2.0' means broader access
More news about: Global Times
Jul 02, 2026, 09:04 ET FUTU SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Futu Holdings Limited (FUTU) Investors of Securities Class Action Lawsuit Deadline on August 25, 2026
further alleges that the regulatory authority "proposes to impose a personal fine of RMB1.25 million (approximately USD 183,575) on Mr. LI Hua, the founder and CEO of the Company." On this news, the price of Futu stock fell more than 27%, according to the complaint.Then, on May 28,
More news about: Faruqi & Faruqi, LLP
Jul 02, 2026, 08:30 ET American Public University and American Military University Honor Student Achievement with Second Quarter 2026 President's List
HazelHaoqing Li
More news about: American Public University System
Jul 02, 2026, 07:59 ET CGTN : D'où vient la confiance du peuple dans le parti au pouvoir en Chine ?
travaille sur le terrain à Chongqing depuis plus de 30 ans et a réussi à régler plus de 2 500 litiges locaux. Dans le même temps, dans le Henan rural, Li Liancheng, secrétaire du Parti du village de Xixinzhuang, a sorti ce dernier d'une grande pauvreté, contribuant ainsi à faire d'un village en difficulté
More news about: CGTN
Jul 02, 2026, 07:49 ET CGTN: O que explica a confiança da população no partido que governa a China?
Chongqing há mais de três décadas e mediou com sucesso mais de 2.500 conflitos locais. Já na zona rural de Henan, o secretário do Partido na aldeia, Li Liancheng, retirou Xixinzhuang da pobreza extrema, ajudando a transformar a localidade de uma vila em dificuldades em um modelo nacional de revitalização
More news about: CGTN
Jul 02, 2026, 07:38 ET CGTN: ¿Qué impulsa la confianza de la población en el partido gobernante de China?
periodo en el cual ha mediado con éxito en más de 2.500 disputas locales. Mientras tanto, en la zona rural de Henan, el jefe del partido de la aldea, Li Liancheng, logró sacar a Xixinzhuang de la pobreza extrema, lo que contribuyó a transformar una aldea en dificultades en un modelo de revitalización
More news about: CGTN
Jul 02, 2026, 07:20 ET CGTN: co sprawia, że Chińczycy darzą zaufaniem partię rządzącą?
publicznej.Ma Shanxiang na przykład od ponad trzech dekad pracuje na szczeblu lokalnym w Chongqingu, skutecznie prowadząc mediacje w ponad 2500 sporach. Z kolei Li Liancheng, sekretarz komórki partyjnej we wsi Xixinzhuang w prowincji Henan, wyprowadził swoją miejscowość z głębokiego ubóstwa, przeobrażając ją w uznawany
More news about: CGTN
Jul 02, 2026, 07:18 ET CGTN: Čo poháňa dôveru ľudí vo vládnucu stranu v Číne?
Čchung-čchingu už viac ako tri desaťročia a úspešne vyriešil viac ako 2 500 miestnych sporov. Medzitým vo vidieckej oblasti Che-nan, predseda strany Li Lien-čcheng (Li Liancheng) vytiahol dedinu Si-sin-čuang (Xixinzhuang) z hlbokej chudoby a pomohol jej premeniť sa z miesta, ktoré sa borí s problémami, na národne
More news about: CGTN
Jul 02, 2026, 06:43 ET CGTN: Apa yang Membuat Partai Komunis Tiongkok Mendapat Kepercayaan Luas dari Publik?
di tingkat akar rumput selama lebih dari 30 tahun dan berhasil menengahi lebih dari 2.500 konflik sosial. Di Provinsi Henan, Kepala Desa Xixinzhuang Li Liancheng berhasil mengangkat desanya keluar dari garis kemiskinan dan menjadikannya salah satu contoh keberhasilan revitalisasi pedesaan di Tiongkok.
More news about: CGTN
Jul 02, 2026, 06:04 ET CGTN: Điều gì tạo nên niềm tin của người dân đối với đảng cầm quyền của Trung Quốc?
Khánh trong hơn ba thập kỷ và hòa giải thành công hơn 2.500 tranh chấp tại địa phương. Trong khi đó, tại vùng nông thôn tỉnh Hà Nam, Bí thư Chi bộ thôn Li Liancheng đã đưa thôn Xixinzhuang thoát khỏi đói nghèo nghiêm trọng, giúp ngôi làng từ tình trạng khó khăn trở thành hình mẫu được công nhận trên toàn
More news about: CGTN
Jul 02, 2026, 03:58 ET HYXI Perkuat Jangkauan di Thailand Lewat Solusi Energi Terbaru untuk Segmen Residensial di Ajang ASEW 2026
di Thailand. Lewat langkah ini, HYXI memperluas jaringan dan memperkuat jangkauan di pasar regional.Country Manager, Thailand, HYXI, Michael Li, mengatakan, "Melalui kemitraan lokal dan inovasi yang berfokus pada kebutuhan pelanggan, HYXI berkomitmen menghadirkan solusi energi yang lebih cerdas
More news about: HYXI
Jul 02, 2026, 03:02 ET Summer Davos highlights 'China Opportunity 2.0' as new growth engine
address to the forum and during symposium exchanges with about 150 business representatives from more than 30 countries and regions, Chinese Premier Li Qiang urged the international community to view the Chinese economy through the lens of "China Opportunity 2.0."This timely concept, now a widely
More news about: chinadiplomacy.org.cn
Jul 02, 2026, 02:27 ET Ribo y Madrigal alcanzan un primer hito importante en el avance de nuevas terapias con siRNA para MASH
este programa de colaboración y proporcionar nuevas y prometedoras opciones terapéuticas a pacientes de todo el mundo que viven con MASH", declaró Li-Ming Gan, co-consejero delegado y presidente global de I+D de Ribo.Acerca de Suzhou Ribo Life Science Co. Ltd. y Ribocure Pharmaceuticals ABSuzhou
More news about: Suzhou Ribo Life Science Co., Ltd.
Jul 02, 2026, 00:43 ET Ribo et Madrigal franchissent une première étape majeure dans le développement de nouvelles thérapies à base d'ARNsi pour la stéatohépatite associée à un dysfonctionnement métabolique (MASH)
ce programme collaboratif et d'offrir de nouvelles options de traitement prometteuses aux patients du monde entier atteints de MASH », a déclaré Li-Ming Gan, co-PDG et président mondial de la recherche et développement chez Ribo.À propos de Suzhou Ribo Life Science Co. Ltd. et Ribocure
More news about: Suzhou Ribo Life Science Co., Ltd.
Jul 01, 2026, 23:58 ET HYXI tăng cường hiện diện tại Thái Lan với các giải pháp năng lượng dân dụng mới tại ASEW 2026
giải pháp năng lượng thông minh và đáng tin cậy hơn cho người dùng Thái Lan, đồng thời hỗ trợ quá trình chuyển dịch năng lượng của khu vực", Michael Li, Giám đốc Quốc gia tại Thái Lan của HYXI cho biết.
More news about: HYXI
Jul 01, 2026, 22:11 ET Jinko ESS and Taliva Energy Sign 400MWh Energy Storage Project Portfolio
energy utilisation, improving energy resilience, and supporting the transition towards a more sustainable and reliable electricity system. Anita Li, Vice President of Jinko ESS, said: "At Jinko ESS, we believe the future of energy requires both innovative technology and trusted local partnerships.
More news about: Jinko ESS
Jul 01, 2026, 22:00 ET 越來越多年輕人受脫髮困擾：REGAINE®*培健引領毛髮科學研究發展
Growth Reports[6] Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y. Risk factors for androgenetic alopecia: a systematic review and meta-analysis.
More news about: REGAINE®
Jul 01, 2026, 22:00 ET 越來越多年輕人受落髮困擾：REGAINE®*落建引領毛髮科學研究發展
Growth Reports[6] Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y. Risk factors for androgenetic alopecia: a systematic review and meta-analysis.
More news about: REGAINE®
Jul 01, 2026, 21:39 ET Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
forward to advancing this collaborative program together and bringing promising new therapeutic options to patients worldwide living with MASH," said Li-Ming Gan, co-CEO & Global R&D President of Ribo.About Suzhou Ribo Life Science Co. Ltd. and Ribocure Pharmaceuticals ABSuzhou
More news about: Suzhou Ribo Life Science Co., Ltd.